Abbott Laboratories Q3 FY25: where the revenue came from and where it went
The whole income statement of Abbott Laboratories for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2025
- Reported
- Oct 29, 2025
Revenue$11.37B
+7% year over year
Gross profit$6.29B
55% margin
Operating profit$2.06B
18% margin
Net profit$1.64B
14% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 11.37 | 100% | +7% |
| Medical devices | 5.45 | 48% | +15% |
| Diagnostic products | 2.25 | 20% | −7% |
| Nutritional products | 2.15 | 19% | +4% |
| Established pharmaceutical | 1.51 | 13% | +7% |
| Cost of revenue | −5.08 | 45% | |
| Gross profit | 6.29 | 55% margin | +0pp |
| R&D | −0.77 | 7% | +0pp |
| SG&A | −3.05 | 27% | +0pp |
| Other | −0.42 | 3% | +0pp |
| Operating profit | 2.06 | 18% margin | +1pp |
| Other income, net | 0.12 | ||
| Tax | −0.54 | ||
| Net profit | 1.64 | 14% margin | −1pp |
378 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest